Careers  |  Sign In  |  Register  |   Twitter

Type 1 Diabetes Vaccine Offers Promising Results

A new study in Science Translational Medicine “suggests an experimental vaccine may be able to tame bits of the immune system that go haywire in people with type 1 diabetes, offering hope for a new way to delay or prevent the autoimmune disease,” Reuters reports. The study is the latest in the hunt for “different ways of manipulating the immune system to stop the destruction of insulin-producing cells” that has lasted for ”more than four decades.” Researchers tested the TOL-3021 DNA vaccine in 80 people diagnosed with type 1 diabetes who were receiving insulin injections, and found that they “showed signs that [the vaccine] helped preserve some of the remaining insulin-producing beta cells in the pancreas without causing serious side effects.”

Read the article published by Reuters.

Read the study in Science Translational Medicine.